Form F-1 MAINZ BIOMED N.V.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Mainz Biomed (MYNZ) files for 30.77M share and warrant offering
November 5, 2024 8:04 AM ESTMainz Biomed (NASDAQ: MYNZ) has filed the following:
We are offering on a best efforts basis up to 30,769,231 ordinary shares of Mainz Biomed N.V. Our ordinary shares are traded on the Nasdaq Capital Market under the symbol MYNZ. The last reported sale price of our ordinary shares on October 30, 2024 as reported on Nasdaq, was $0.26 per share rounded to the nearest whole cent, which is the per share offering price we have assumed for purposes of this preliminary prospectus.
We are also offering to each purchaser of ordinary shares that would otherwise result in the... More
